Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,916 | 32,301 | 86,225 | 22,470 | 35,691 |
| Marketable Securities | 100,665 | 70,758 | 59,711 | 44,089 | 33,024 |
| Receivables | 855 | 426 | 676 | 1,090 | 772 |
| TOTAL | $122,436 | $103,485 | $146,612 | $67,649 | $69,487 |
| Non-Current Assets | |||||
| PPE Net | 885 | 849 | 791 | 387 | 104 |
| Investments And Advances | 20,008 | 50,046 | 16,666 | 32,664 | 38,623 |
| TOTAL | $20,893 | $50,895 | $17,457 | $33,051 | $38,727 |
| Total Assets | $143,329 | $154,380 | $164,069 | $100,700 | $108,214 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,824 | 9,519 | 8,564 | 8,497 | 5,723 |
| TOTAL | $5,824 | $9,519 | $8,564 | $8,497 | $5,723 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 562 | 197 | 142 | 114 | 106 |
| TOTAL | $562 | $197 | $142 | $114 | $106 |
| Total Liabilities | $6,386 | $9,716 | $8,706 | $8,611 | $5,829 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,171 | 1,171 | 1,171 | 861 | 861 |
| Retained earnings | -156,635 | -148,278 | -137,034 | -128,888 | -117,987 |
| Other shareholders' equity | -205 | -169 | -8 | 72 | -47 |
| TOTAL | $136,943 | $144,664 | $155,363 | $92,089 | $102,385 |
| Total Liabilities And Equity | $143,329 | $154,380 | $164,069 | $100,700 | $108,214 |